AzTrials
AzTrials

Neuromuscular PerformanceNCT07843199

Effects of Resistance Exercise Timing on Midday Muscle Performance in Athletes

A study testing Resistance-Based PAPE Intervention in people with Neuromuscular Performance and Post-Activation Performance Enhancement (PAPE), run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigated whether the timing of a resistance-based post-activation performance enhancement (PAPE) intervention performed during the morning influences muscle performance and muscle electrical activity during a standardized midday assessment in trained male athletes. Read more about this study

Who is it for?
Any age, men onlyHealthy volunteers can take part
What is being tested?
Resistance-Based PAPE Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
13 participants
Where
1 siteTurkey (Türkiye)
Study dates
3 Jun 2025to 15 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Men only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Regularly participating in systematic sport-specific training (minimum training age of 3 years)
  • Able to comply with pre-testing restrictions (avoidance of intense physical activity for 72 hours and caffeine for 2 hours prior to testing sessions)

Who cannot join

  • Any musculoskeletal, orthopedic, or health condition preventing safe participation in maximal isokinetic exercise testing
  • Current or recent injury affecting lower-limb strength or performance testing

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Manisa Celal Bayar University, Faculty of Sport Sciences

    Manisa, 45040

Other trials in Turkey (Türkiye)

About this study

Official title: Time-Course Effect of Post-Activation Performance Enhancement on Midday Peak Torque and Muscle Activation

This study investigated whether the timing of a resistance-based post-activation performance enhancement (PAPE) intervention performed during the morning influences muscle performance and muscle electrical activity during a standardized midday assessment in trained male athletes. Participants completed a control condition and three PAPE conditions performed at different times during the morning. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises. In all conditions, muscle performance was assessed between 12:00 and 12:15 using an isokinetic dynamometer, while surface electromyography (sEMG) of the rectus femoris muscle was recorded. The study compared relative peak torque and sEMG spectral power across the different PAPE timing conditions and the control condition.

Being tested
Resistance-Based PAPE Intervention
Keywords
Time of Day, spectral power, Midday performance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistance-Based PAPE InterventionBehavioural

    The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

Study groups in NCT07843199
Study groupRoleWhat they receive
Control (C)No interventionParticipants completed the standardized midday isokinetic performance assessment without a PAPE intervention. The assessment consisted of four maximal repetitions on an isokinetic dynamometer at 60°·s-¹ between 12:00 and 12:15, while rectus femoris surface electromyography was recorded.
PAPE T1ExperimentalParticipants performed the standardized PAPE intervention between 08:00 and 09:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.
Receives: Behavioral: Resistance-Based PAPE Intervention
PAPE T2ExperimentalParticipants performed the standardized PAPE intervention between 10:00 and 11:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.
Receives: Behavioral: Resistance-Based PAPE Intervention
PAPE T3ExperimentalParticipants performed the standardized PAPE intervention between 11:45 and 12:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.
Receives: Behavioral: Resistance-Based PAPE Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Relative Peak Torque (RPT)

    Relative peak torque (RPT) was determined from the highest peak torque value obtained during four maximal knee extension repetitions performed on an isokinetic dynamometer at 60°·s-¹. Peak torque was normalized to body mass and expressed as N·m·kg-¹.

    Measured: Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

  2. Rectus Femoris sEMG Spectral Power

    Surface electromyography (sEMG) of the rectus femoris muscle was recorded during the maximal isokinetic knee extension repetitions. Spectral power was calculated from the processed sEMG signal using fast Fourier transform (FFT) analysis and expressed as µV²/Hz.

    Measured: Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2026
  2. Study start3 Jun 2025
  3. Primary completion20 Aug 2025
  4. Study completion15 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
All participants completed four experimental conditions (control, T1, T2, and T3) in a randomized order, with at least 48 hours between conditions. The performance assessment was conducted between 12:00 and 12:15 in all conditions.
Masking
None (open label)
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07843199
Sponsor's protocol ID
MCBU_PAPE_2025
Status last verified
Sep 2026
First submitted
15 Sep 2026
Last updated
25 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data are not planned to be publicly shared due to participant confidentiality and data protection considerations.

Questions about this trial

What is this clinical trial studying?

A study testing Resistance-Based PAPE Intervention in people with Neuromuscular Performance and Post-Activation Performance Enhancement (PAPE), run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Relative Peak Torque (RPT) (time frame: Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in